{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:41:21Z","timestamp":1722991281794},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66275","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:10:38Z","timestamp":1722949838000},"source":"Crossref","is-referenced-by-count":0,"title":["A Case of Multibacillary Borderline Lepromatous Leprosy in the United States Treated With Alternative Therapy"],"prefix":"10.7759","author":[{"given":"Nicholas","family":"Chin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Logan R","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sudeep","family":"Gaudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brooke","family":"Baldwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Leprosy (Hansen\u2019s disease): an update and review","volume":"120","author":"Gilmore A","year":"2023","unstructured":"Gilmore A, Roller J, Dyer JA. Leprosy (Hansen\u2019s disease): an update and review. Mo Med. 2023, 120:39-44.","journal-title":"Mo Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.698588","article-title":"Mycobacterium lepromatosis as a second agent of Hansen's disease","volume":"12","author":"Deps P","year":"2021","unstructured":"Deps P, Collin SM. Mycobacterium lepromatosis as a second agent of Hansen's disease. Front Microbiol. 2021, 12:698588. 10.3389\/fmicb.2021.698588","journal-title":"Front Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/PHAR.1009","article-title":"Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions","volume":"32","author":"Legendre DP","year":"2012","unstructured":"Legendre DP, Muzny CA, Swiatlo E. Hansen's disease (Leprosy): current and future pharmacotherapy and treatment of disease-related immunologic reactions. Pharmacotherapy. 2012, 32:27-37. 10.1002\/PHAR.1009","journal-title":"Pharmacotherapy"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104475","article-title":"Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options","volume":"149","author":"Mungroo MR","year":"2020","unstructured":"Mungroo MR, Khan NA, Siddiqui R. Mycobacterium leprae: Pathogenesis, diagnosis, and treatment options. Microb Pathog. 2020, 149:104475. 10.1016\/j.micpath.2020.104475","journal-title":"Microb Pathog"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008276","article-title":"Reservoirs and transmission routes of leprosy; a systematic review","volume":"14","author":"Ploemacher T","year":"2020","unstructured":"Ploemacher T, Faber WR, Menke H, Rutten V, Pieters T. Reservoirs and transmission routes of leprosy; a systematic review. PLoS Negl Trop Dis. 2020, 14:e0008276. 10.1371\/journal.pntd.0008276","journal-title":"PLoS Negl Trop Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/00128071-200102040-00001","article-title":"Leprosy. Recognition and treatment","volume":"2","author":"Ramos-e-Silva M","year":"2001","unstructured":"Ramos-e-Silva M, Rebello PF. Leprosy. Recognition and treatment. Am J Clin Dermatol. 2001, 2:203-11. 10.2165\/00128071-200102040-00001","journal-title":"Am J Clin Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2141987","article-title":"Pathogenicity and virulence of Mycobacterium leprae","volume":"13","author":"Sugawara-Mikami M","year":"2022","unstructured":"Sugawara-Mikami M, Tanigawa K, Kawashima A, Kiriya M, Nakamura Y, Fujiwara Y, Suzuki K. Pathogenicity and virulence of Mycobacterium leprae. Virulence. 2022, 13:1985-2011. 10.1080\/21505594.2022.2141987","journal-title":"Virulence"},{"key":"ref8","article-title":"Guidelines for the diagnosis, treatment and prevention of leprosy","year":"2017","unstructured":"Guidelines for the diagnosis, treatment and prevention of leprosy. World Health Organization, Regional Office for South-East Asia, New Delh; 2017."},{"key":"ref9","unstructured":"NHDP guide to the management of Hansen\u2019s disease. Health Resources and Services Administration. Accessed. May 5, 2024: https:\/\/www.hrsa.gov\/sites\/default\/files\/hrsa\/hansens-disease\/hansens-disease-guide-management.pdf."},{"key":"ref10","unstructured":"National Hansen's disease (leprosy) program caring and curing since 1894. (2024). Accessed. May 3, 2024: https:\/\/www.hrsa.gov\/hansens-disease."},{"key":"ref11","unstructured":"Florida Department of Health BoE. Hansen's disease. (2024). Accessed: May 3, 2024: https:\/\/www.flhealthcharts.gov\/ChartsDashboards\/rdPage.aspx."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.22-0751","article-title":"Quantitative real-time polymerase chain reaction for detection of Mycobacterium leprae DNA in tissue specimens from patients with leprosy","volume":"109","author":"Sarath IM","year":"2023","unstructured":"Sarath IM, Joseph NM, Jamir I. Quantitative real-time polymerase chain reaction for detection of Mycobacterium leprae DNA in tissue specimens from patients with leprosy. Am J Trop Med Hyg. 2023, 109:345-9. 10.4269\/ajtmh.22-0751","journal-title":"Am J Trop Med Hyg"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3201\/eid2112.150501","article-title":"Zoonotic leprosy in the southeastern United States","volume":"21","author":"Sharma R","year":"2015","unstructured":"Sharma R, Singh P, Loughry WJ, et al.. Zoonotic leprosy in the southeastern United States. Emerg Infect Dis. 2015, 21:2127-34. 10.3201\/eid2112.150501","journal-title":"Emerg Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.47276\/lr.93.2.96","article-title":"Safer and newer antimicrobial drugs for leprosy - time to test monthly rom in an adequately powered randomised trial?","author":"Lockwood D","year":"2022","unstructured":"Lockwood D, Penna G, Lambert S, Pai V, Walker S. Safer and newer antimicrobial drugs for leprosy - time to test monthly rom in an adequately powered randomised trial?. Lepr Rev. 2022, 10.47276\/lr.93.2.96","journal-title":"Lepr Rev"},{"key":"ref15","article-title":"A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone","volume":"79","author":"Sapkota BR","year":"2008","unstructured":"Sapkota BR, Shrestha K, Pandey B, Walker SL. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone. Lepr Rev. 2008, 79:425-8.","journal-title":"Lepr Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/20499361221135885","article-title":"Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States","volume":"9","author":"Franco-Paredes C","year":"2022","unstructured":"Franco-Paredes C, Garcia-Creighton E, Henao-Mart\u00ednez A, et al.. Novel approaches in the treatment of Hansen's disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States. Ther Adv Infect Dis. 2022, 9:20499361221135885. 10.1177\/20499361221135885","journal-title":"Ther Adv Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01162-07","article-title":"Powerful bactericidal activity of moxifloxacin in human leprosy","volume":"52","author":"Pardillo FE","year":"2008","unstructured":"Pardillo FE, Burgos J, Fajardo TT, et al.. Powerful bactericidal activity of moxifloxacin in human leprosy. Antimicrob Agents Chemother. 2008, 52:3113-7. 10.1128\/AAC.01162-07","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.5935\/0305-7518.20000074","article-title":"Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy","volume":"71 Suppl","author":"Ji B","year":"2000","unstructured":"Ji B, Grosset J. Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy. Lepr Rev. 2000, 71 Suppl:S81-7. 10.5935\/0305-7518.20000074","journal-title":"Lepr Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger CB","year":"2011","unstructured":"Granger CB, Alexander JH, McMurray JJ, et al.. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011, 365:981-92. 10.1056\/NEJMoa1107039","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.647","article-title":"Drug interactions with apixaban: a systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports","volume":"8","author":"Fernandez S","year":"2020","unstructured":"Fernandez S, Lenoir C, Samer C, Rollason V. Drug interactions with apixaban: a systematic review of the literature and an analysis of VigiBase, the World Health Organization database of spontaneous safety reports. Pharmacol Res Perspect. 2020, 8:e00647. 10.1002\/prp2.647","journal-title":"Pharmacol Res Perspect"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270430-a-case-of-multibacillary-borderline-lepromatous-leprosy-in-the-united-states-treated-with-alternative-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T13:10:44Z","timestamp":1722949844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270430-a-case-of-multibacillary-borderline-lepromatous-leprosy-in-the-united-states-treated-with-alternative-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.66275","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}